NCT06244966

Brief Summary

Capillary blood sample results are compared to venous blood results

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at below P25 for not_applicable hiv-infections

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 6, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

April 10, 2024

Status Verified

April 1, 2024

Enrollment Period

1 year

First QC Date

January 16, 2024

Last Update Submit

April 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparative capillary and venous samples screening testing

    To have sufficient parallel samples (capillary and venous) collected to demonstrate equivalence of the results of HIV, HBV, HCV and syphilis testing using the Roche Cobas e601 platform

    1 year

Secondary Outcomes (1)

  • Comparative capillary and venous samples confirmatory testing

    1 year

Study Arms (1)

Any client attending clinic for venous blood sampling

EXPERIMENTAL

Any client attending clinic for venous blood sampling for sexually transmitted disease diagnostics will also collect capillary blood using a finger prick

Diagnostic Test: HIV diagnostic testing

Interventions

HIV diagnostic testingDIAGNOSTIC_TEST

Finger-prick capillary blood will be tested alongside venous blood

Also known as: Syphilis diagnostic testing, Hepatitis diagnostic testing
Any client attending clinic for venous blood sampling

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults
  • Able and willing to provide informed consent.
  • Already having a venous blood sample for clinical care

You may not qualify if:

  • Failure to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Devon University Hospital NHS Foundation Trust

Exeter, Devon, EX2 5AD, United Kingdom

Location

MeSH Terms

Conditions

HIV InfectionsHepatitis BHepatitis C

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesHepadnaviridae InfectionsDNA Virus InfectionsHepatitis, Viral, HumanHepatitisLiver DiseasesDigestive System DiseasesFlaviviridae Infections

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Comparative study of two collection methods for blood samples
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2024

First Posted

February 6, 2024

Study Start

May 1, 2024

Primary Completion

May 1, 2025

Study Completion

May 1, 2025

Last Updated

April 10, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

No data will be shared

Locations